We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Engineered cartilage using primary chondrocytes cultured in a porous cartilage-derived matrix

    Nai-Chen Cheng

    Departments of Orthopedic Surgery & Biomedical Engineering, Duke University Medical Center, Durham, NC 27710, USA

    Institute of Biomedical Engineering, College of Medicine & College of Engineering, National Taiwan University, Taipei, 100 Taiwan

    Department of Surgery, National Taiwan University Hospital & College of Medicine, Taipei, 100 Taiwan

    ,
    Bradley T Estes

    Departments of Orthopedic Surgery & Biomedical Engineering, Duke University Medical Center, Durham, NC 27710, USA

    ,
    Tai-Horng Young

    Institute of Biomedical Engineering, College of Medicine & College of Engineering, National Taiwan University, Taipei, 100 Taiwan

    &
    Published Online:https://doi.org/10.2217/rme.10.87

    Aim: To investigate the cell growth, matrix accumulation and mechanical properties of neocartilage formed by human or porcine articular chondrocytes on a porous, porcine cartilage-derived matrix (CDM) for use in cartilage tissue engineering. Materials & methods: We examined the physical properties, cell infiltration and matrix accumulation in different formulations of CDM and selected a CDM made of homogenized cartilage slurry as an appropriate scaffold for long-term culture of human and porcine articular chondrocytes. Results: The CDM scaffold supported growth and proliferation of both human and porcine chondrocytes. Histology and immunohistochemistry showed abundant cartilage-specific macromolecule deposition at day 28. Human chondrocytes migrated throughout the CDM, showing a relatively homogeneous distribution of new tissue accumulation, whereas porcine chondrocytes tended to form a proteoglycan-rich layer primarily on the surfaces of the scaffold. Human chondrocyte-seeded scaffolds had a significantly lower aggregate modulus and hydraulic permeability at day 28. Conclusions: These data show that a scaffold derived from native porcine articular cartilage can support neocartilage formation in the absence of exogenous growth factors. The overall characteristics and properties of the constructs depend on factors such as the concentration of CDM used, the porosity of the scaffold, and the species of chondrocytes.

    Bibliography

    • Jackson DW, Simon TM, Aberman HM: Symptomatic articular cartilage degeneration: the impact in the new millennium. Clin. Orthop. Relat. Res. (391 Suppl.),S14–S25 (2001).
    • Lynn AK, Brooks RA, Bonfield W, Rushton N: Repair of defects in articular joints. Prospects for material-based solutions in tissue engineering. J. Bone Joint Surg. Br.86(8),1093–1099 (2004).
    • Grande DA, Pitman MI, Peterson L, Menche D, Klein M: The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation. J. Orthop. Res.7(2),208–218 (1989).
    • Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L: Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med.331(14),889–895 (1994).
    • Knutsen G, Engebretsen L, Ludvigsen TC et al.: Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J. Bone Joint Surg. Am.86-A(3),455–464 (2004).
    • Awad HA, Halvorsen YD, Gimble JM, Guilak F: Effects of transforming growth factor-β1 and dexamethasone on the growth and chondrogenic differentiation of adipose-derived stromal cells. Tissue Eng.9(6),1301–1312 (2003).
    • Guilak F, Butler DL, Goldstein SA: Functional tissue engineering: the role of biomechanics in articular cartilage repair. Clin. Orthop. Relat. Res. (391 Suppl.),S295–S305 (2001).
    • Aigner J, Tegeler J, Hutzler P et al.: Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester. J. Biomed. Mater. Res.42(2),172–181 (1998).
    • Mierisch CM, Cohen SB, Jordan LC, Robertson PG, Balian G, Diduch DR: Transforming growth factor-β in calcium alginate beads for the treatment of articular cartilage defects in the rabbit. Arthroscopy18(8),892–900 (2002).
    • 10  Iwasaki N, Yamane ST, Majima T et al.: Feasibility of polysaccharide hybrid materials for scaffolds in cartilage tissue engineering: evaluation of chondrocyte adhesion to polyion complex fibers prepared from alginate and chitosan. Biomacromolecules5(3),828–833 (2004).
    • 11  Domm C, Schunke M, Steinhagen J, Freitag S, Kurz B: Influence of various alginate brands on the redifferentiation of dedifferentiated bovine articular chondrocytes in alginate bead culture under high and low oxygen tension. Tissue Eng.10(11–12),1796–1805 (2004).
    • 12  Buschmann MD, Gluzband YA, Grodzinsky AJ, Hunziker EB: Mechanical compression modulates matrix biosynthesis in chondrocyte/agarose culture. J. Cell Sci.108(Pt 4),1497–1508 (1995).
    • 13  Mauck RL, Nicoll SB, Seyhan SL, Ateshian GA, Hung CT: Synergistic action of growth factors and dynamic loading for articular cartilage tissue engineering. Tissue Eng.9(4),597–611 (2003).
    • 14  Mauck RL, Soltz MA, Wang CC et al.: Functional tissue engineering of articular cartilage through dynamic loading of chondrocyte-seeded agarose gels. J. Biomech. Eng.122(3),252–260 (2000).
    • 15  Nettles DL, Elder SH, Gilbert JA: Potential use of chitosan as a cell scaffold material for cartilage tissue engineering. Tissue Eng.8(6),1009–1016 (2002).
    • 16  Cao Y, Rodriguez A, Vacanti M, Ibarra C, Arevalo C, Vacanti CA: Comparative study of the use of poly(glycolic acid), calcium alginate and pluronics in the engineering of autologous porcine cartilage. J. Biomater. Sci. Polym. Ed.9(5),475–487 (1998).
    • 17  Chang SC, Rowley JA, Tobias G et al.: Injection molding of chondrocyte/alginate constructs in the shape of facial implants. J. Biomed. Mater. Res.55(4),503–511 (2001).
    • 18  Fragonas E, Valente M, Pozzi-Mucelli M et al.: Articular cartilage repair in rabbits by using suspensions of allogenic chondrocytes in alginate. Biomaterials21(8),795–801 (2000).
    • 19  Hendrickson DA, Nixon AJ, Grande DA et al.: Chondrocyte–fibrin matrix transplants for resurfacing extensive articular cartilage defects. J. Orthop. Res.12(4),485–497 (1994).
    • 20  Kurz B, Domm C, Jin M, Sellckau R, Schunke M: Tissue engineering of articular cartilage under the influence of collagen I/III membranes and low oxygen tension. Tissue Eng.10(7–8),1277–1286 (2004).
    • 21  Dausse Y, Grossin L, Miralles G et al.: Cartilage repair using new polysaccharidic biomaterials: macroscopic, histological and biochemical approaches in a rat model of cartilage defect. Osteoarthr. Cartil.11(1),16–28 (2003).
    • 22  Kang Y, Yang J, Khan S, Anissian L, Ameer GA: A new biodegradable polyester elastomer for cartilage tissue engineering. J. Biomed. Mater. Res. A77(2),331–339 (2006).
    • 23  Bryant SJ, Anseth KS: Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J. Biomed. Mater. Res.59(1),63–72 (2002).
    • 24  Lee WK, Ichi T, Ooya T, Yamamoto T, Katoh M, Yui N: Novel poly(ethylene glycol) scaffolds crosslinked by hydrolyzable polyrotaxane for cartilage tissue engineering. J. Biomed. Mater. Res. A67(4),1087–1092 (2003).
    • 25  Freed LE, Vunjak-Novakovic G, Langer R: Cultivation of cell-polymer cartilage implants in bioreactors. J. Cell Biochem.51(3),257–264 (1993).
    • 26  Martin I, Obradovic B, Treppo S et al.: Modulation of the mechanical properties of tissue engineered cartilage. Biorheology37(1–2),141–147 (2000).
    • 27  Urist MR: Bone: formation by autoinduction. Science150(698),893–899 (1965).
    • 28  Badylak SF: The extracellular matrix as a biologic scaffold material. Biomaterials28(25),3587–3593 (2007).
    • 29  Badylak SF, Freytes DO, Gilbert TW: Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater.5(1),1–13 (2009).
    • 30  Chang Y, Lee MH, Liang HC, Hsu CK, Sung HW: Acellular bovine pericardia with distinct porous structures fixed with genipin as an extracellular matrix. Tissue Eng.10(5–6),881–892 (2004).
    • 31  Ott HC, Matthiesen TS, Goh SK et al.: Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat. Med.14(2),213–221 (2008).
    • 32  Little D, Guilak F, Ruch DS: Ligament-derived matrix stimulates a ligamentous phenotype in human adipose-derived stem cells. Tissue Eng. Part A16(7),2307–2319 (2010).
    • 33  Ponce Marquez S, Martinez VS, McIntosh Ambrose W et al.: Decellularization of bovine corneas for tissue engineering applications. Acta Biomater.5(6),1839–1847 (2009).
    • 34  Hwang NS, Varghese S, Puleo C, Zhang Z, Elisseeff J: Morphogenetic signals from chondrocytes promote chondrogenic and osteogenic differentiation of mesenchymal stem cells. J. Cell Physiol.212(2),281–284 (2007).
    • 35  Cheng NC, Estes BT, Awad HA, Guilak F: Chondrogenic differentiation of adipose-derived adult stem cells by a porous scaffold derived from native articular cartilage extracellular matrix. Tissue Eng. Part A15(2),231–241 (2009).
    • 36  Diekman BO, Rowland CR, Caplan AI, Lennon D, Guilak F: Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage derived matrix. Tissue Eng. Part A16(2),523–533 (2009).
    • 37  Lin YC, Tan FJ, Marra KG, Jan SS, Liu DC: Synthesis and characterization of collagen/hyaluronan/chitosan composite sponges for potential biomedical applications. Acta Biomater.5(7),2591–2600 (2009).
    • 38  Guilak F, Erickson GR, Ting-Beall HP: The effects of osmotic stress on the viscoelastic and physical properties of articular chondrocytes. Biophys. J.82(2),720–727 (2002).
    • 39  Darling EM, Athanasiou KA: Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J. Orthop. Res.23(2),425–432 (2005).
    • 40  Farndale RW, Buttle DJ, Barrett AJ: Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim. Biophys. Acta883(2),173–177 (1986).
    • 41  Woessner JF Jr: The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch. Biochem. Biophys.93,440–447 (1961).
    • 42  Mow VC, Kuei SC, Lai WM, Armstrong CG: Biphasic creep and stress-relaxation of articular-cartilage in compression – theory and experiments. J. Biomech. Eng.102(1),73–84 (1980).
    • 43  Bachrach NM, Mow VC, Guilak F: Incompressibility of the solid matrix of articular cartilage under high hydrostatic pressures. J. Biomech.31(5),445–451 (1998).
    • 44  Bi X, Yang X, Bostrom MP, Camacho NP: Fourier transform infrared imaging spectroscopy investigations in the pathogenesis and repair of cartilage. Biochim. Biophys. Acta1758(7),934–941 (2006).
    • 45  Potter K, Kidder LH, Levin IW, Lewis EN, Spencer RG: Imaging of collagen and proteoglycan in cartilage sections using Fourier transform infrared spectral imaging. Arthritis Rheum.44(4),846–855 (2001).
    • 46  Basad E, Ishaque B, Bachmann G, Sturz H, Steinmeyer J: Matrix-induced autologous chondrocyte implantation versus microfracture in the treatment of cartilage defects of the knee: a 2-year randomised study. Knee Surg. Sports Traumatol. Arthrosc.18(4),519–527 (2010).
    • 47  Kuo CK, Li WJ, Mauck RL, Tuan RS: Cartilage tissue engineering: its potential and uses. Curr. Opin. Rheumatol.18(1),64–73 (2006).
    • 48  Wang Y, Kim UJ, Blasioli DJ, Kim HJ, Kaplan DL: In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials26(34),7082–7094 (2005).
    • 49  Leddy HA, Awad HA, Guilak F: Molecular diffusion in tissue-engineered cartilage constructs: effects of scaffold material, time, and culture conditions. J. Biomed. Mater. Res. B Appl. Biomater.70(2),397–406 (2004).
    • 50  Macchiarini P, Jungebluth P, Go T et al.: Clinical transplantation of a tissue-engineered airway. Lancet372(9655),2023–2030 (2008).
    • 51  Yang Q, Peng J, Guo Q et al.: A cartilage ECM-derived 3-D porous acellular matrix scaffold for in vivo cartilage tissue engineering with PKH26-labeled chondrogenic bone marrow-derived mesenchymal stem cells. Biomaterials29(15),2378–2387 (2008).
    • 52  Bobick BE, Chen FH, Le AM, Tuan RS: Regulation of the chondrogenic phenotype in culture. Birth Defects Res. C Embryo Today87(4),351–371 (2009).
    • 53  Vincent TL, McLean CJ, Full LE, Peston D, Saklatvala J: FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer. Osteoarthr. Cartil.15(7),752–763 (2007).
    • 54  Zhu Y, Oganesian A, Keene DR, Sandell LJ: Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-β1 and BMP-2. J. Cell Biol.144(5),1069–1080 (1999).
    • 55  Betre H, Ong SR, Guilak F, Chilkoti A, Fermor B, Setton LA: Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide. Biomaterials27(1),91–99 (2006).
    • 56  Boskey A, Pleshko Camacho N: FT-IR imaging of native and tissue-engineered bone and cartilage. Biomaterials28(15),2465–2478 (2007).
    • 57  O’Brien FJ, Harley BA, Yannas IV, Gibson LJ: The effect of pore size on cell adhesion in collagen–GAG scaffolds. Biomaterials26(4),433–441 (2005).
    • 58  O’Brien FJ, Harley BA, Waller MA, Yannas IV, Gibson LJ, Prendergast PJ: The effect of pore size on permeability and cell attachment in collagen scaffolds for tissue engineering. Technol. Health Care15(1),3–17 (2007).
    • 59  Schulze-Tanzil G, Muller RD, Kohl B et al.: Differing in vitro biology of equine, ovine, porcine and human articular chondrocytes derived from the knee joint: an immunomorphological study. Histochem. Cell Biol.131(2),219–229 (2009).
    • 60  Akens MK, Hurtig MB: Influence of species and anatomical location on chondrocyte expansion. BMC Musculoskelet. Disord.6,23 (2005).
    • 61  Giannoni P, Crovace A, Malpeli M et al.: Species variability in the differentiation potential of in vitro-expanded articular chondrocytes restricts predictive studies on cartilage repair using animal models. Tissue Eng.11(1–2),237–248 (2005).
    • 62  Diekman BO, Rowland CR, Caplan AI, Lennon D, Guilak F: Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage derived matrix. Tissue Eng. Part A16(2),523–533 (2009).
    • 63  Valonen PK, Moutos FT, Kusanagi A et al.: In vitro generation of mechanically functional cartilage grafts based on adult human stem cells and 3D-woven poly(ε-caprolactone) scaffolds. Biomaterials31(8),2193–2200 (2010).
    • 64  Athanasiou KA, Rosenwasser MP, Buckwalter JA, Malinin TI, Mow VC: Interspecies comparisons of in situ intrinsic mechanical properties of distal femoral cartilage. J. Orthop. Res.9(3),330–340 (1991).
    • 65  Cavallo C, Desando G, Facchini A, Grigolo B: Chondrocytes from patients with osteoarthritis express typical extracellular matrix molecules once grown onto a three-dimensional hyaluronan-based scaffold. J. Biomed. Mater. Res. A93(1),86–95 (2009).
    • 66  Seda Tigli R, Ghosh S, Laha MM et al.: Comparative chondrogenesis of human cell sources in 3D scaffolds. J. Tissue Eng. Regen. Med.3(5),348–360 (2009).
    • 67  Freed LE, Engelmayr J, Borenstein JT, Moutos FT, Guilak F: Advanced material strategies for tissue engineering scaffolds. Adv. Mater.21(32–33),3410–3418 (2009).
    • 68  Discher DE, Mooney DJ, Zandstra PW: Growth factors, matrices, and forces combine and control stem cells. Science324(5935),1673–1677 (2009).
    • 69  Freed LE, Guilak F, Guo XE et al.: Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng.12(12),3285–3305 (2006).
    • 70  Guilak F, Awad HA, Fermor B, Leddy HA, Gimble JM: Adipose-derived adult stem cells for cartilage tissue engineering. Biorheology41(3–4),389–399 (2004).
    • 71  Estes BT, Gimble JM, Guilak F: Mechanical signals as regulators of stem cell fate. Curr. Top Dev. Biol.60,91–126 (2004).